Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. Jul 16, 2011; 3(7): 133-139
Published online Jul 16, 2011. doi: 10.4253/wjge.v3.i7.133
Published online Jul 16, 2011. doi: 10.4253/wjge.v3.i7.133
Management of early gastrointestinal neuroendocrine neoplasms
Hans Scherübl, Departments of Gastroenterology, Gastrointestinal Oncology and Infectious Diseases, Vivantes Klinikum Am Urban, Berlin 10967, Germany
Robert T Jensen, Digestive Diseases Branch, NIH, Bethesda, MD 20892, United States
Guillaume Cadiot, Service d’Hépato-Gastroentérologie, Hôpital Robert Debré, Reims 51092, France
Ulrich Stölzel, Departments of Gastroenterology and Gastrointestinal Oncology, Klinikum Chemnitz, Chemnitz 09116, Germany
Günter Klöppel, Department of Pathology, Technical University München, Klinikum rechts der Isar, München 81675, Germany
Author contributions: Scherübl H performed data aquisition, manuscript conception and writing; Jensen RT performed clinical interpretation and writing; Cadiot G performed clinical interpretation and writing; Stölzel U performed clinical interpretation and writing; Klöppel G performed clinical interpretation, manuscript conception and writing.
Correspondence to: Hans Scherübl, MD, Professor, Klinik für Innere Medizin - Gastroenterologie, Gastrointestinale Onkologie und Infektiologie, Vivantes-Klinikum Am Urban, Akademisches Lehrkrankenhaus der Charité, Dieffenbachstrasse 1, Berlin 10967, Germany. hans.scheruebl@vivantes.de
Telephone: +49-30-130225201 Fax: +49-30-130225205
Received: January 15, 2011
Revised: May 4, 2011
Accepted: May 18, 2011
Published online: July 16, 2011
Revised: May 4, 2011
Accepted: May 18, 2011
Published online: July 16, 2011
Core Tip